Comprehensive Dermatologic Drug Therapy 2021
DOI: 10.1016/b978-0-323-61211-1.00041-3
|View full text |Cite
|
Sign up to set email alerts
|

Topical Antibacterial Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 247 publications
0
5
0
Order By: Relevance
“…Moreover, the authors observed its efficiency in diminishing hyperpigmentation. The effectiveness of azelaic acid in decreasing hyperpigmentation has been confirmed in many studies and for this reason the acid is widely used in cosmetology and dermatology 25–28 . Moreover, some studies have reported the role of this compound in the reduction of post‐inflammatory hyperpigmentation, or hyperpigmentation caused by phototoxic reactions 29,30 .…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…Moreover, the authors observed its efficiency in diminishing hyperpigmentation. The effectiveness of azelaic acid in decreasing hyperpigmentation has been confirmed in many studies and for this reason the acid is widely used in cosmetology and dermatology 25–28 . Moreover, some studies have reported the role of this compound in the reduction of post‐inflammatory hyperpigmentation, or hyperpigmentation caused by phototoxic reactions 29,30 .…”
Section: Discussionmentioning
confidence: 87%
“…The effectiveness of azelaic acid in decreasing hyperpigmentation has been confirmed in many studies and for this reason the acid is widely used in cosmetology and dermatology. [25][26][27][28] Moreover, some studies have reported the role of this compound in the reduction of post-inflammatory hyperpigmentation, or hyperpigmentation caused by phototoxic reactions. 29,30 In turn, PA is an alpha-hydroxy acid used mainly for skin exfoliation and lightening.…”
Section: (Cheek)mentioning
confidence: 99%
“…Finally, in special populations, i.e., in persons pregnant or lactating, it is not advisable to administer clindamycin. Concerning oral administration, unless the necessity for its use outweighs the risks, oral clindamycin in the long term is cautioned against and topical clindamycin (i.e., for acne treatment) is not suggested as (i) clindamycin can be found in breast milk and (ii) safety considerations of clindamycin for dermatologic use when pregnant or breastfeeding have not been holistically described [ 71 , 77 , 82 , 83 ]. Overall, it is pertinent to acknowledge that clindamycin is a suitable treatment option for a range of dermatologic indications, but also that safety, efficacy, and individual patient histories must be considered when prescribing clindamycin in accordance with evidence based medicine.…”
Section: Efficacy and Use Of Clindamycin In Dermatologic Diseasementioning
confidence: 99%
“…Microbial resistance is found to be settled in prolonged treatment, being associated as well with skin reactions like erythema, scaling, dryness which will further influence the patient adherence. The efficacy of the proposed treatment may be compromised in the case of antibiotics like erythromycin or nadifloxacin [ 303 , 304 ]. For erythromycin, a study of Ochiuz and Hortolomei, revealed the importance of choosing the appropriate S/CoS mixture in the formulation study.…”
Section: Microemulsions In a New Vision For An Optimized Acne Thermentioning
confidence: 99%